Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS08 - Symposium by Pfizer: EGFR+ and ALK+ NSCLC: More Options, Right Choices (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/08/2019
- Location: Vienna (2016)
- Type: Industry Symposia & Workshops
- Track:
-
+
ES01 - What Is the Role of Chemotherapy in the Era of Immunotherapy in Advanced NSCLC?
- 10:30 - 12:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Oscar Gerardo Arrieta, Reyes Bernabe
-
+
ES01.03 - Chemotherapy Directly Targets the Immune System to Improve Efficacy
11:00 - 11:15 | Presenter: Daniel SW Tan
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-107 - KEYNOTE-495/KeyImPaCT: Phase 2 Biomarker-Directed Study of Pembrolizumab-Based Therapy for Non–Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Martin Gutierrez | Author(s): Matthew Hellmann, Matthew A. Gubens, Charu Aggarwal, Daniel SW Tan, Enriqueta Felip, Wei-Sen Lam, Joanne Wing Yan Chiu, Jong-Seok Lee, James Chih-Hsin Yang, Edward Garon, Andrea Basso, Hua Ma, Lawrence Fong, Alex Snyder, Jianda Yuan, Roy S. Herbst
- Abstract
Loading...
-
+
P1.09 - Pathology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Pathology
-
+
P1.09-19 - High-Throughput Next Generation Sequencing of Treatment-Naïve Non-Squamous NSCLC: The Singapore National Lung Profiling Study
09:45 - 09:45 | Presenter: Aaron C Tan | Author(s): Gillianne Lai, Gek San Tan, Shou Yu Poon, Brett Doble, Tse Hui Lim, Zaw Win Aung, Angela Takano, Wan Ling Tan, Mei Kim Ang, Bien Soo Tan, Anantham Devanand, Chow Wei Too, Apoorva Gogna, Boon Hean Ong, Tina Koh, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Tanujaa Rajasekaran, Alvin Lim, Wan Teck Lim, Chee Keong Toh, Eng Huat Tan, Kiat Hon Lim, Daniel SW Tan
- Abstract
Loading...
-
+
P1.17 - Treatment of Early Stage/Localized Disease
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P1.17-07 - Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study
09:45 - 09:45 | Presenter: Aaron C Tan | Author(s): Khi Pin Chua, Angela Takano, Jacob Alvarez, Boon Hean Ong, Tina Koh, Zaw Win Aung, Amit Jain, Gillianne Lai, Wan Ling Tan, Mei Kim Ang, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, N Gopalakrishna Iyer, Wan Teck Lim, Weiwei Zhai, Chee Keong Toh, Anders Skanderup, Eng Huat Tan, Daniel SW Tan
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-17 - CANOPY-1: Phase 3 Study of Canakinumab/Placebo+Pembrolizumab+Platinum-Chemotherapy in Untreated Stage IIIB-IV NSCLC Pts
10:15 - 10:15 | Presenter: Enriqueta Felip | Author(s): Gilberto Castro, Alastair Greystoke, Benjamin J Solomon, Daniel SW Tan, Vanessa Q. Passos, Stephanie Deudon, Anne Laure Louveau, Bruce E Johnson
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-20 - ATORG-003: Dacomitinib With or Without Dose Titration as First-Line Therapy for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Aaron C Tan | Author(s): Tony Mok, Dong-Wan Kim, James Chih-Hsin Yang, Chee Lee, Ross Soo, Thanyanan Reungwetwattana, Daniel SW Tan, Herbert H. Loong
- Abstract
Loading...
-
+
ES24 - Diagnosis and Management of Side Effects of Immunotherapy
- 11:30 - 13:00
- 9/10/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-oncology
- Moderators:Daniel SW Tan, Joachim G.J.V. Aerts
-
+
ES24.01 - Recognizing Toxicities in an Early Phase in PDL1 Treatment
11:30 - 11:50 | Presenter: Hossein Borghaei
- Abstract
No abstract available for this presentation
-
+
ES24.02 - Renal Toxicities in Combination I/O Chemotherapy Treatment
11:50 - 12:10 | Presenter: Joachim G.J.V. Aerts
- Abstract
No abstract available for this presentation
-
+
ES24.03 - Management of Immunerelated Toxicities Unresponsive to Steroids
12:10 - 12:30 | Presenter: Anne Tsao
- Abstract
No abstract available for this presentation
-
+
ES24.04 - Q&A
12:30 - 13:00
- Abstract
No abstract available for this presentation
-
+
PL04 - Food for Thought in the Management of Thoracic Malignancies
- 16:15 - 17:00
- 9/10/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track: Advanced NSCLC
- Moderators:Daniel SW Tan, Ramon Rami-Porta
-
+
PL04.01 - Epidemiology and Clinical Characteristics of Lung Cancer in Women
16:15 - 16:25 | Presenter: Enriqueta Felip
- Abstract
Loading... -
+
PL04.02 - What Does Survivorship Mean in the World of Immunotherapy (Physical and Financial)?
16:25 - 16:35 | Presenter: Michelle Turner
- Abstract
Loading... -
+
PL04.03 - The Relevance of an International Database for the Study of Thymic Neoplasms
16:35 - 16:45 | Presenter: Vanessa Bolejack
- Abstract
Loading... -
+
PL04.04 - Prognostic Factors in Malignant Pleural Mesothelioma
16:45 - 16:55 | Presenter: Michaela B Kirschner
- Abstract
Loading... -
+
PL04.05 - Q&A
16:55 - 17:00
- Abstract
No abstract available for this presentation